EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights

Ali B. Roomi, Wurood Al-Kariti, Asmaa A. Metwally

AACE Endocrinology and Diabetes · 2026-10

DOI: 10.1016/j.aed.2026.08.036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AACE Endocrinology and Diabetes, 2026-10. Verfasst von Ali B. Roomi und 2 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Roomi, A. B., Al-Kariti, W., & Metwally, A. A. (2026). Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights. AACE Endocrinology and Diabetes. https://doi.org/10.1016/j.aed.2026.08.036

Vancouver

Roomi AB, Al-Kariti W, Metwally AA. Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights. AACE Endocrinology and Diabetes. 2026. doi:10.1016/j.aed.2026.08.036

BibTeX
@article{Roomi2026,
  author = {Roomi, Ali B. and Al-Kariti, Wurood and Metwally, Asmaa A.},
  title = {Irisin as a Novel Modulator of Bone Remodeling in Paget’s disease: Clinical Insights},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  doi = {10.1016/j.aed.2026.08.036}
}
Kostenlos starten →